Carlsen A, Steinsbo O, Kvaloy JT, Aabakken L, et al. Optimizing serum adalimumab levels in maintenance therapy via proactive therapeutic drug monitoring improves markers of disease activity in Crohn's disease. Scand J Gastroenterol 2025 Oct 17:1-12. doi: 10.1080/00365521.2025.2573725.
PMID: 41105383